PALISADE BIO, INC. — Director's Dealing 2014

May 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-05-01

Reporting Person: JOHE KARL (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-01	Common Stock	S	6000	$3.5425	Disposed	502247	Direct

Footnotes

F1: The transaction reported was effected pursuant to a 10b-5 trading plan.

F2: This transaction was executed in multiple trades at prices ranging from $3.49 to $3.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.